clinical trial Archive — Page 5 of 16

(iStock)
October 4, 2024

‘Off-the-shelf’ CAR-T therapy shows promise for relapsed/refractory multiple myeloma 

The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial.

Patient lying in a hospital bed wearing a surgical cap and breathing through a clear oxygen mask connected to tubing; a gloved clinician is blurred in the foreground.
August 21, 2024

High or low oxygen levels are safe during heart surgery: study

Two hundred study participants were assessed for oxidative stress, acute kidney injury, delirium, myocardial injury and atrial fibrillation.

Stylized 3D anatomical illustration of the human lungs and heart, with the trachea and branching airways visible against a softly blurred background.
August 20, 2024

VUMC participating in clinical trial of novel heart failure treatment  

Patients with a form of heart failure called HFpEF may breathe normally at rest but quickly become breathless with physical activity. The study will test an atrial shunt to relieve high pressure in the heart.

Wesley Self, MD, MPH, smiles while posing in a black suit, white shirt, and blue striped tie in a bright building interior.
July 12, 2024

Wesley Self named to leadership role in global clinical trials network

The Strategies and Treatments for Respiratory Infections and Viral Emergencies network includes more than 300 sites around the world and international experts in clinical trials, infectious diseases, critical care and pandemic preparedness.

Conceptual biotechnology scene showing gloved laboratory workers, test tubes, a pipette, and overlaid medical graphics including DNA-like molecular structures, human anatomy icons, a heartbeat waveform, charts, and a digital human figure.
July 10, 2024

Clinical trial for rectal cancer subtype shows promise for less aggressive treatment

The findings were so promising that the clinical trial is being redesigned to investigate whether radiation treatment can also be avoided.

3D rendering of an enterovirus D68 particle covered by red, yellow, and blue viral proteins and orange and purple antibodies, overlaid on a colorized electron micrograph showing green virus particles.
June 28, 2024

Antibody trial launched to address enterovirus threat

Enterovirus D68 has caused an increasing number of infections during the past decade and is associated with acute flaccid myelitis, a polio-like condition that mostly affects children and causes sudden weakness and paralysis.